Peptic ulcer disease
MONDO:0004247A digestive system disease characterized by discontinuation in the inner lining of the gastrointestinal (GI) tract because of gastric acid secretion or pepsin.
Also known as: acute peptic ulcer with haemorrhage, acute peptic ulcer with haemorrhage and perforation, acute peptic ulcer without haemorrhage and without perforation, peptic ulcer
67 clinical trials for this condition and its sub-types, 26 tagged with Peptic ulcer disease itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Peptic ulcer disease
-
Peptic esophagitis 24 trials
-
Gastric ulcer 13 trials
1 sub-type
- Gastroduodenitis 0 trials
-
Duodenal ulcer 7 trials
-
Gastrojejunal ulcer 6 trials
-
Active peptic ulcer disease 3 trials
-
Peptic ulcer perforation 3 trials
-
Children's heartburn drug study halted early
Disease control Stopped earlyThis study looked at whether a full or half dose of pantoprazole could keep the esophagus healed in children aged 1 to 17 who had erosive esophagitis. The goal was to see which dose worked better and was safer. The study was stopped early, so results are limited.
Phase 2 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Children's heartburn drug trial halted early – but data may still help
Disease control Stopped earlyThis study tested a daily medicine called dexlansoprazole to heal and prevent return of erosive esophagitis (damage to the esophagus from stomach acid) in children aged 2 to 11 years. The trial was stopped early, but researchers aimed to see if the drug could heal the esophagus w…
Phase 2 • Sponsor: Takeda • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC